Published in

Elsevier, Revista da Associação Médica Brasileira, 1(68), p. 3-8, 2022

DOI: 10.1590/1806-9282.2022d681

Links

Tools

Export citation

Search in Google Scholar

Use of disease-modifying drugs (tocilizumab, tofacitinib, and baricitinib—a biological or synthetic target specific) in patients hospitalized with COVID-19

Journal article published in 2022 by Alexandre Naime Barbosa ORCID, Antonio Silvinato ORCID, Hélio Bacha ORCID, Idevaldo Floriano ORCID, Suzana Tanni ORCID, Wanderley Bernardo ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO